keyword
https://read.qxmd.com/read/38666966/epidemiology-and-burden-of-ventilator-associated-pneumonia-among-adult-intensive-care-unit-patients-a-portuguese-multicenter-retrospective-study-evap-pt-study
#1
JOURNAL ARTICLE
Paulo Mergulhão, João Gonçalves Pereira, Antero Vale Fernandes, Andriy Krystopchuk, João Miguel Ribeiro, Daniel Miranda, Heloísa Castro, Carla Eira, Juvenal Morais, Cristina Lameirão, Sara Gomes, Dina Leal, Joana Duarte, Leonor Pássaro, Filipe Froes, Ignacio Martin-Loeches
Ventilator-associated pneumonia (VAP) is a prevailing nosocomial infection in critically ill patients requiring invasive mechanical ventilation (iMV). The impact of VAP is profound, adversely affecting patient outcomes and placing a significant burden on healthcare resources. This study assessed for the first time the contemporary VAP epidemiology in Portugal and its burden on the healthcare system and clinical outcomes. Additionally, resource consumption (duration of iMV, intensive care unit (ICU), hospital length of stay (LOS)) and empirical antimicrobial therapy were also evaluated...
March 22, 2024: Antibiotics
https://read.qxmd.com/read/38662372/abatacept-pharmacokinetics-and-exposure-response-in-patients-hospitalized-with-covid-19-a-secondary-analysis-of-the-activ-1-im-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Stephen J Balevic, Daniel K Benjamin, William G Powderly, P Brian Smith, Daniel Gonzalez, Matthew W McCarthy, Linda K Shaw, Christopher J Lindsell, Sam Bozzette, Daphne Williams, Benjamin P Linas, John Blamoun, Heta Javeri, Christoph P Hornik
IMPORTANCE: The pharmacokinetics of abatacept and the association between abatacept exposure and outcomes in patients with severe COVID-19 are unknown. OBJECTIVE: To characterize abatacept pharmacokinetics, relate drug exposure with clinical outcomes, and evaluate the need for dosage adjustments. DESIGN, SETTING, AND PARTICIPANTS: This study is a secondary analysis of data from the ACTIV-1 (Accelerating COVID-19 Therapeutic Interventions and Vaccines) Immune Modulator (IM) randomized clinical trial conducted between October 16, 2020, and December 31, 2021...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38662217/dysphagia-rehabilitation-in-dysphagic-patients-with-acute-or-critical-illness-a-systematic-review-and-meta-analysis
#3
JOURNAL ARTICLE
Akira Kuriyama, Shinichi Watanabe, Yukiko Katayama, Taisuke Yasaka, Akira Ouchi, Yuki Iida, Fumihito Kasai
Dysphagia or swallowing dysfunction is common in patients with acute or critical illness, and diverse methods of dysphagia rehabilitation are provided worldwide. We aimed to examine the efficacy of rehabilitation to treat dysphagia in patients with acute or critical illness. We searched PubMed, ICHUSHI, and Cochrane Central Register of Controlled Trials databases from inception to November 22, 2023 for relevant randomized controlled trials. We focused on dysphagic patients with acute or critical illness who were not orotracheally intubated...
April 25, 2024: Dysphagia
https://read.qxmd.com/read/38660495/evaluating-antibiotic-treatment-guideline-adherence-to-ongoing-antibiotic-stewardship-in-a-tertiary-care-setting-a-retrospective-observational-study
#4
JOURNAL ARTICLE
Suman Pant, Andrew Corwin, Prabhat Adhikari, Subhash Prasad Acharya, Upasana Acharya, Sashi Silwal, Pratima Dawadi, Anil Poudyal, Vibhu Paudyal, Adisak Bhumiratana
Antimicrobial resistance (AMR) is widely regarded as an increasing threat to global public health. Antibiotic treatment guidelines have been increasingly recognized as an effective tool to guide appropriate prescriptions and help curtail antibiotic resistance. The present study aimed to assess physician's adherence to hospital antibiotic treatment guideline recommendations in Nepal and determine predictive variables with a significant association. This was a retrospective, monocentric observational review to investigate the adherence to endorsed guidelines using the medical records of adults admitted to the hospital with a diagnosis of urinary tract infection (UTI), pneumonia, or skin and soft tissue infection (SSTI) from January 2018 to December 2019...
2024: Canadian Journal of Infectious Diseases & Medical Microbiology
https://read.qxmd.com/read/38652542/new-evidence-on-the-impacts-of-cross-market-hospital-mergers-on-commercial-prices-and-measures-of-quality
#5
JOURNAL ARTICLE
Daniel R Arnold, Jaime S King, Brent D Fulton, Alexandra D Montague, Katherine L Gudiksen, Thomas L Greaney, Richard M Scheffler
OBJECTIVE: To examine the impact of "cross-market" hospital mergers on prices and quality and the extent to which serial acquisitions contribute to any measured effects. DATA SOURCES: 2009-2017 commercial claims from the Health Care Cost Institute (HCCI) and quality measures from Hospital Compare. STUDY DESIGN: Event study models in which the treated group consisted of hospitals that acquired hospitals further than 50 miles, and the control group was hospitals that were not part of any merger activity (as a target or acquirer) during the study period...
April 23, 2024: Health Services Research
https://read.qxmd.com/read/38652528/research-hotspot-and-frontiers-in-post-stroke-dysphagia-a-bibliometric-study-and-visualisation-analysis
#6
JOURNAL ARTICLE
Qinzhi Hou, Liqing Yao, Jibing Ou
BACKGROUND: Dysphagia, a common complication after stroke, significantly hampers the recovery process of patients, both due to dysphagia itself and the additional complications it causes. Although a large number of articles have been published on post-stroke dysphagia (PSD), bibliometric analysis in this field is still lacking. This study aimed to provide a comprehensive understanding of the research hotspots and trends in PSD, thereby guiding future research efforts. METHODS: The Web of Science Core Collection (WoSCC) database was searched for articles related to PSD from 2003 to 2022...
April 23, 2024: Journal of Evaluation in Clinical Practice
https://read.qxmd.com/read/38649652/coma-prevalence-in-critical-care-units-in-chile-results-of-a-cross-sectional-survey-on-world-coma-day
#7
JOURNAL ARTICLE
Andrés Giglio, Andrés Reccius, Tomás Regueira, Cristóbal Carvajal, Cesar Pedreros, Monserrat Pino, Carolina Riquelme, Sergio Aguilera, Andrés Ferre, José Ignacio Suarez
BACKGROUND: The purpose of this study was to assess the prevalence of coma among patients in critical care units in Chile. We also aimed to provide insight into the demographic characteristics, etiologies, and complications associated with coma. METHODS: A single day cross-sectional study was conducted through a national survey of public and private hospitals with critical and intensive cardiac care units across Chile. Data were collected using an online questionnaire that contained questions regarding critically ill patients' information, demographic characteristics, etiology and duration of coma, medical complications, and support requirements...
April 22, 2024: Neurocritical Care
https://read.qxmd.com/read/38646395/differentiating-leukostasis-from-covid-19-pneumonia-clinical-and-radiological-perspectives-for-the-right-decision-making
#8
Nouama Bouanani, Ibtihal Abouchabaka
Leukostasis is a non-infectious complication of acute leukemia. Pathophysiologically, it is characterized by an accumulation of blasts in the pulmonary capillaries. Clinically, this syndrome of hyperleukocytosis or leucocytosis leads to pulmonary and/or neurological lesions. This is why it must be treated urgently to prevent it from progressing to acute respiratory distress. In 2020, the World Health Organization (WHO) declared a pandemic caused by a novel coronavirus called SARS-CoV-2, which may cause respiratory distress or other clinical, biological, and radiological signs that some may confuse with those of leukostasis...
March 2024: Curēus
https://read.qxmd.com/read/38641389/optimizing-diagnosis-and-management-of-community-acquired-pneumonia-in-the-emergency-department
#9
REVIEW
Katherine M Hunold, Elizabeth Rozycki, Nathan Brummel
Pneumonia is split into 3 diagnostic categories: community-acquired pneumonia (CAP), health care-associated pneumonia, and ventilator-associated pneumonia. This classification scheme is driven not only by the location of infection onset but also by the predominant associated causal microorganisms. Pneumonia is diagnosed in over 1.5 million US emergency department visits annually (1.2% of all visits), and most pneumonia diagnosed by emergency physicians is CAP.
May 2024: Emergency Medicine Clinics of North America
https://read.qxmd.com/read/38640940/global-burden-associated-with-85-pathogens-in-2019-a-systematic-analysis-for-the-global-burden-of-disease-study-2019
#10
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Despite a global epidemiological transition towards increased burden of non-communicable diseases, communicable diseases continue to cause substantial morbidity and mortality worldwide. Understanding the burden of a wide range of infectious diseases, and its variation by geography and age, is pivotal to research priority setting and resource mobilisation globally. METHODS: We estimated disability-adjusted life-years (DALYs) associated with 85 pathogens in 2019, globally, regionally, and for 204 countries and territories...
April 16, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38636536/global-regional-and-national-incidence-and-mortality-burden-of-non-covid-19-lower-respiratory-infections-and-aetiologies-1990-2021-a-systematic-analysis-from-the-global-burden-of-disease-study-2021
#11
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Lower respiratory infections (LRIs) are a major global contributor to morbidity and mortality. In 2020-21, non-pharmaceutical interventions associated with the COVID-19 pandemic reduced not only the transmission of SARS-CoV-2, but also the transmission of other LRI pathogens. Tracking LRI incidence and mortality, as well as the pathogens responsible, can guide health-system responses and funding priorities to reduce future burden. We present estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 of the burden of non-COVID-19 LRIs and corresponding aetiologies from 1990 to 2021, inclusive of pandemic effects on the incidence and mortality of select respiratory viruses, globally, regionally, and for 204 countries and territories...
April 15, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38630736/comorbidities-and-their-association-with-covid-19-mortality-in-mexico-between-january-2020-and-august-2021
#12
JOURNAL ARTICLE
Ryan J Lowhorn, Mohammed Chowdhury, Symon Kimitei, Sammie Haskin, Mohammad Masum, A K M Fazlur Rahman
By August 17, 2021, 4.3 million people had died globally as a result of SARS-CoV-2 infection. While data collection is ongoing, it is abundantly obvious that this is one of the most significant public health crises in modern history. Consequently, global efforts are being made to attain a greater understanding of this disease and to identify risk factors associated with more severe outcomes. The goal of this study is to identify clinical characteristics and risk factors associated with COVID-19 mortality in Mexico...
2024: PloS One
https://read.qxmd.com/read/38628848/impact-of-influenza-related-hospitalization-in-spain-characteristics-and-risk-factor-of-mortality-during-five-influenza-seasons-2016-to-2021
#13
JOURNAL ARTICLE
José-Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Pilar González-de-la-Aleja, José Sánchez-Payá, Sergio Reus, Juan-Carlos Rodríguez-Díaz, Esperanza Merino
BACKGROUND: Estimating the global influenza burden in terms of hospitalization and death is important for optimizing prevention policies. Identifying risk factors for mortality allows for the design of strategies tailored to groups at the highest risk. This study aims to (a) describe the clinical characteristics of hospitalizations with a diagnosis of influenza over five flu seasons (2016-2017 to 2020-2021), (b) assess the associated morbidity (hospitalization rates and ICU admissions rate), mortality and cost of influenza hospitalizations in different age groups and (c) analyze the risk factors for mortality...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38619436/household-air-pollution-interventions-to-improve-health-in-low-and-middle-income-countries-an-official-american-thoracic-society-research-statement
#14
JOURNAL ARTICLE
Peggy S Lai, Nicholas L Lam, Bill Gallery, Alison G Lee, Heather Adair-Rohani, Donee Alexander, Kalpana Balakrishnan, Iwona Bisaga, Zoe A Chafe, Thomas Clasen, Anaité Díaz-Artiga, Andrew Grieshop, Kat Harrison, Stella M Hartinger, Darby Jack, Seyram Kaali, Melissa Lydston, Kevin M Mortimer, Laura Nicolaou, Esther Obonyo, Gabriel Okello, Christopher Olopade, Ajay Pillarisetti, Alisha Noella Pinto, Joshua P Rosenthal, Neil Schluger, Xiaoming Shi, Claudia Thompson, Lisa M Thompson, John Volckens, Kendra N Williams, John Balmes, William Checkley, Obianuju B Ozoh
Background: An estimated 3 billion people, largely in low- and middle-income countries, rely on unclean fuels for cooking, heating, and lighting to meet household energy needs. The resulting exposure to household air pollution (HAP) is a leading cause of pneumonia, chronic lung disease, and other adverse health effects. In the last decade, randomized controlled trials of clean cooking interventions to reduce HAP have been conducted. We aim to provide guidance on how to interpret the findings of these trials and how they should inform policy makers and practitioners...
April 15, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38615185/predicting-covid-19-outcomes-with-the-edmonton-obesity-staging-system
#15
JOURNAL ARTICLE
Sajjad Ali, Omar Sufyan Khan, Amira M Youssef, Iram Saba, Leena Alqahtani, Renad Abdulaziz Alduhaim, Renad Almesned
BACKGROUND: Multiple studies have demonstrated a correlation between a high body mass index and discriminatory COVID-19 outcomes. Studies appear to indicate that there is a correlation between obesity-related comorbidities and less favorable outcomes. OBJECTIVES: The primary aim of the current investigation is to conduct a thorough assessment of the correlation between BMI and comorbidities associated with obesity, and their potential impact on the severity and consequences of COVID-19 infection among patients receiving care in a tertiary healthcare setting...
2024: Annals of Saudi Medicine
https://read.qxmd.com/read/38613215/use-of-nursing-care-bundles-for-the-prevention-of-ventilator-associated-pneumonia-in-low-middle-income-countries-a-scoping-review
#16
REVIEW
Amyna Ismail Rehmani, Alesia Au, Carmel Montgomery, Elizabeth Papathanassoglou
BACKGROUND: Ventilator-associated pneumonia (VAP) is a significant concern in low-middle-income countries (LMICs), where the burden of hospital-acquired infections is high, and resources are low. Evidence-based guidelines exist for preventing VAP; however, these guidelines may not be adequately utilized in intensive care units of LMICs. AIM: This scoping review examined the literature regarding the use of nursing care bundles for VAP prevention in LMICs, to understand the knowledge, practice and compliance of nurses to these guidelines, as well as the barriers preventing the implementation of these guidelines...
April 13, 2024: Nursing in Critical Care
https://read.qxmd.com/read/38610171/systematic-review-and-meta-analysis-of-the-financial-impact-of-30-day-readmissions-for-selected-medical-conditions-a-focus-on-hospital-quality-performance
#17
REVIEW
Iwimbong Kum Ghabowen, Josue Patien Epane, Jay J Shen, Xan Goodman, Zo Ramamonjiarivelo, Ferhat Devrim Zengul
BACKGROUND: The Patient Protection and Affordable Care Act (ACA) established the Hospital Quality Initiative in 2010 to enhance patient safety, reduce hospital readmissions, improve quality, and minimize healthcare costs. In response, this study aims to systematically review the literature and conduct a meta-analysis to estimate the average cost of procedure-specific 30-day risk-standardized unplanned readmissions for Acute Myocardial Infarction (AMI), Heart Failure (HF), Pneumonia, Coronary Artery Bypass Graft (CABG), and Total Hip Arthroplasty and/or Total Knee Arthroplasty (THA/TKA)...
March 29, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38609806/evaluating-the-health-and-economic-outcomes-of-a-pcv15-vaccination-program-for-adults-aged-65%C3%A2-years-and-above-in-switzerland
#18
JOURNAL ARTICLE
Kwame Owusu-Edusei, Andrea Favre-Bulle, Eleana Tsoumani, Thomas Mutschler, Nicole Cossrow
OBJECTIVE: To assess the health and economic outcomes of a PCV13 or PCV15 age-based (65 years-and-above) vaccination program in Switzerland. INTERVENTIONS: The three vaccination strategies examined were:Target population: All adults aged 65 years-and-above. Perspective(s): Switzerland health care payer. TIME HORIZON: 35 years. Discount rate: 3.0%. Costing year: 2023 Swiss Francs (CHF). STUDY DESIGN: A static Markov state-transition model...
April 11, 2024: Vaccine
https://read.qxmd.com/read/38597355/reducing-unwarranted-chest-x-rays-in-bronchiolitis-importance-of-a-robust-analysis
#19
JOURNAL ARTICLE
Joanna Lawrence, Harriet Hiscock, Alice Voskoboynik, Ramesh Walpola, Anurag Sharma
AIM: Bronchiolitis is the commonest reason for hospitalisation amongst infants and is often a target for low-value care (LVC) reduction. We aimed to assess the impact of a multifaceted intervention (clinician education, parent engagement, audit-feedback) on rates of chest x-rays (CXR) in bronchiolitis. METHODS: Longitudinal study of CXRs ordered in infants (1-12 months) diagnosed with bronchiolitis in the Emergency Department (ED) of an Australian paediatric hospital between May 2016 and February 2023...
April 10, 2024: Journal of Paediatrics and Child Health
https://read.qxmd.com/read/38593462/high-incidence-of-antibiotic-resistance-in-the-uropathogenic-bacteria-associated-with-different-urological-diseases-and-metabolic-complications-a-single-center-cross-sectional-study
#20
JOURNAL ARTICLE
Yuvarajan Subramaniyan, Altaf Khan, M Mujeeburahiman, Punchappady Devasya Rekha
Urological diseases affect all age groups and are associated with different urinary complications. Presence of pathogenic bacteria complicates the urological diseases such as chronic kidney disease (CKD), kidney stone disease (KSD), emphysematous pyelonephritis (EPN), and urological cancers (UCs) coinciding with urinary metabolic complications. The One Health concept for preventing the spread of antibiotic resistant opportunistic pathogens necessitates detailed investigation on the virulence and the antibiotic sensitivity patterns of the pathogens from the urinary tract infections (UTIs)...
April 8, 2024: Microbial Drug Resistance: MDR: Mechanisms, Epidemiology, and Disease
keyword
keyword
107182
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.